003850.KS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 09:30):

Boryung Corporation produces and sells pharmaceutical products in South Korea. The company offers cardiovascular products, anticancer products, gastrointestinal products, and API's...

Stats
Dzisiejszy wolumen	141 374
Średni wolumen	382 153
Kapitalizacja rynkowa	739.01B
EPS	KRW0 ( 2024-04-28 )
Następna data zysków	( KRW0 ) 2024-07-25
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW9.58 (0.09%)

Wolumen Korelacja

Długi: -0.02 (neutral)

Krótki: 0.30 (neutral)

Signal:(82.991) Neutral

Boryung Corporation Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Boryung Corporation Korelacja - Waluta/Towar

0.24
( neutral )

0.12
( neutral )

0.44
( neutral )

0.39
( neutral )

0.00
( neutral )

-0.16
( neutral )

Boryung Corporation Finanse

Annual	2023
Przychody:	KRW859.63B
Zysk brutto:	KRW333.27B (38.77 %)
EPS:	KRW610.38

FY	2023
Przychody:	KRW859.63B
Zysk brutto:	KRW333.27B (38.77 %)
EPS:	KRW610.38

FY	2022
Przychody:	KRW760.48B
Zysk brutto:	KRW307.19B (40.39 %)
EPS:	KRW635.91

FY	2021
Przychody:	KRW627.28B
Zysk brutto:	KRW264.94B (42.24 %)
EPS:	KRW725.84

Financial Reports:

No articles found.

Boryung Corporation

Boryung Corporation produces and sells pharmaceutical products in South Korea. The company offers cardiovascular products, anticancer products, gastrointestinal products, and API's. It also exports its products to approximately 50 countries on 6 continents, including Japan, China, the Southeast Asia, the Middle East, Europe, South America, and Africa. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is based in Seoul, South Korea.